23 results
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... anticoagulants (DOACs ... #Cancer #Algorithm ... Anticoagulation #Management #Hematology ... #Oncology
(DOAC interactions) Cancer-treatment specific inducers (↑) and inhibitors (↓)
of cytochrome p450 CYP3A4 and P-glycoprotein.

DOACs are substrates
(DOAC interactions ... DOACs are substrates ... #Chemotherapy #Oncology ... #Hematology #Interactions ... #Table #Pharmacology
Breast Mass - Diagnostic Workup Algorithm (Younger than 30)

- BWH Medicine Chiefs @BrighamChiefs

#Breast #Mass #Diagnosis #Workup
Breast Mass - Diagnostic ... Workup Algorithm ... #Mass #Diagnosis ... #Workup #Algorithm ... #Young #oncology
Most Common Breast Masses - Comparison between Fibroadenoma, Cysts and Cancer

#Diagnosis #Oncology #Breast #Masses #Comparison #Table
Most Common Breast ... and Cancer #Diagnosis ... #Oncology #Breast ... Masses #Comparison #Table
Map of proliferative blood disorders. 

By Ariella Coler-Reilly @ariellastudies

#Algorithm #classification #proliferative #blood #disorders #leukemia #hematology #oncology
ariellastudies #Algorithm ... disorders #leukemia #hematology ... #oncology #diagnosis
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
Treatment algorithm ... DOAC, direct oral ... #DOAC #VTE #Malignancy ... Anticoagulation #Management #Hematology ... #Oncology
Causes of Diffuse and Localized Lymphadenopathy - Differential Diagnosis Algorithm
 • Reactive (Inflammatory / Infectious)
 •
- Differential Diagnosis ... Algorithm • Reactive ... #Differential #Diagnosis ... #Algorithm #Causes ... #Hematology #Oncology
Causes of Localized Lymphadenopathy - Differential Diagnosis Algorithm
Cervical:
 - Anterior
     • Infection
- Differential Diagnosis ... Algorithm Cervical ... #Differential #Diagnosis ... #Algorithm #Causes ... #Hematology #Oncology
Multiple Myeloma - Treatment Algorithm
a) Newly Diagnosed Myeloma: Transplant Eligible
b) Newly Diagnosed Myeloma: Transplant Ineligible

doi: 10.1038/s41408-020-00359-2

#Multiple
Myeloma - Treatment Algorithm ... a) Newly Diagnosed ... Eligible b) Newly Diagnosed ... #management #hematology ... #oncology
Who to test for BRCA 1/2?
Female Breast Cancer:
 • ≤ 45-50 years at diagnosis
 • Triple
45-50 years at diagnosis ... cancers in this table ... factors in this table ... #indications #oncology ... #screening #diagnosis